Although reduced in-vivo sEH activity in CKD/ESRD [4,16] may have contributed to the increased accumulation of the four eicosanoid classes itself, our data indicate that the observed changes are likely related to reduced sEH activity by HD treatment. This evidence concerns the gene EPHX2 and chronic kidney disease.